Boehringer-Ingelheim ' s-half-year-figures-2021

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and developmentBreakthrough results in the treatment of a type of heart failure, which is extremely difficult to manageStrong progress in mental health pipelineGood business performance in all areas, despite ongoing impact of COVID-19
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news